Medpace (MEDP) EBITDA (2015 - 2026)
Medpace (MEDP) EBITDA from Sep 30, 2015 to Mar 31, 2026. The TTM Medpace (MEDP) EBITDA is $590M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Medpace (MEDP) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +21.88% |
| 3 Years TTM | +22.53% |
| 5 Years TTM | +25.16% |
| 10 Years TTM | +38.06% |
| All Time TTM | +31.10% |
Annual EBITDA change of Medpace (MEDP)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $148M | -73.63% |
| 2025 | $562M | +18.42% |
| 2024 | $475M | +31.51% |
| 2023 | $361M | +21.25% |
| 2022 | $298M | +38.71% |
| 2021 | $215M | +20.11% |
| 2020 | $179M | +31.76% |
| 2019 | $136M | +22.97% |
| 2018 | $110M | +50.20% |
| 2017 | $73M | +22.53% |
| 2016 | $60M | +122.46% |
| 2015 | $27M | N/A |
Comparison Medpace (MEDP) five years EBITDA CAGR with competitors
Medpace (MEDP) five years EBITDA CAGR is 25.16%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| PRPH | ProPhase Labs Inc | 73.15% | +190.75% |
| ISPC | iSpecimen Inc | 25.14% | -0.09% |
| PSNL | Personalis Inc | 18.83% | -25.17% |
| WAT | Waters Corp | 17.45% | -30.63% |
| BNR | Burning Rock Biotech Ltd | 17.26% | -31.39% |
| ICLR | Icon Plc | 12.53% | -50.19% |
| IDXX | Idexx Laboratories Inc | 11.66% | -53.64% |
| CSTL | Castle Biosciences Inc | 10.29% | -59.11% |
| MTD | Mettler-Toledo International Inc | 9.87% | -60.78% |
| MYNZ | Mainz Biomed N.V. | 9.82% | -60.97% |
| IQV | IQVIA Holdings Inc | 9.14% | -63.66% |
| RDNT | Radnet Inc | 8.38% | -66.67% |
| IMDX | Insight Molecular Diagnostics Inc | 7.62% | -69.73% |
| A | Agilent Technologies Inc | 6.59% | -73.81% |
| ILMN | Illumina Inc | 5.98% | -76.22% |
| GH | Guardant Health Inc | 5.67% | -77.46% |
| NTRA | Natera Inc | 3.35% | -86.68% |
| TWST | Twist Bioscience Corp | 2.84% | -88.72% |
| BDSX | Biodesix Inc | 2.43% | -90.33% |
| SHC | Sotera Health Company | 2.32% | -90.77% |
| QGEN | Qiagen NV | 2.21% | -91.24% |